CA2199255A1 - Vaccin contre des infections vaginales s'administrant par voie enterique - Google Patents

Vaccin contre des infections vaginales s'administrant par voie enterique

Info

Publication number
CA2199255A1
CA2199255A1 CA002199255A CA2199255A CA2199255A1 CA 2199255 A1 CA2199255 A1 CA 2199255A1 CA 002199255 A CA002199255 A CA 002199255A CA 2199255 A CA2199255 A CA 2199255A CA 2199255 A1 CA2199255 A1 CA 2199255A1
Authority
CA
Canada
Prior art keywords
vaccine
killed
vagina
oestrogen
microorganisms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002199255A
Other languages
English (en)
Inventor
Robert Llewellyn Clancy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Auspharm International Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2199255A1 publication Critical patent/CA2199255A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0002—Fungal antigens, e.g. Trichophyton, Aspergillus, Candida
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)

Abstract

Vaccin s'administrant par voie entérique et exempt de composés déclenchant une réaction antigénique, à savoir des adjuvants. Ce vaccin comprend un micro-organisme tué infectant le vagin. Ce micro-organisme peut être un champignon, tel que Candida albicans, une bactérie, telle que Gardnerella vaginalis ou Neisseria gonorrhoea, un protozoaire, tel que Trichomonas vaginalis ou un virus, tel que Herpes genitalis. L'absence d'adjuvant permet d'améliorer considérablement la clairance des micro-organismes par rapport aux compositions contenant des adjuvants.
CA002199255A 1994-09-06 1995-09-05 Vaccin contre des infections vaginales s'administrant par voie enterique Abandoned CA2199255A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9417880.3 1994-09-06
GB9417880A GB9417880D0 (en) 1994-09-06 1994-09-06 Vaccine

Publications (1)

Publication Number Publication Date
CA2199255A1 true CA2199255A1 (fr) 1996-03-14

Family

ID=10760876

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002199255A Abandoned CA2199255A1 (fr) 1994-09-06 1995-09-05 Vaccin contre des infections vaginales s'administrant par voie enterique

Country Status (12)

Country Link
EP (1) EP0779817A1 (fr)
JP (1) JPH10505083A (fr)
KR (1) KR970705409A (fr)
CN (1) CN1159760A (fr)
AU (1) AU3353095A (fr)
CA (1) CA2199255A1 (fr)
FI (1) FI970933L (fr)
GB (1) GB9417880D0 (fr)
IL (1) IL115197A (fr)
NO (1) NO971003L (fr)
WO (1) WO1996007426A1 (fr)
ZA (1) ZA957482B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0834322A3 (fr) * 1996-10-04 1998-04-22 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Vaccins pour traiter des mycoses
US7135191B2 (en) * 1997-09-04 2006-11-14 Zsolt Istvan Hertelendy Urogenital or anorectal transmucosal vaccine delivery system
BR0111785A (pt) * 2000-06-19 2003-05-20 Candivax Pty Ltd Composições e métodos para tratamento de candidìase

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2617870A1 (de) * 1975-04-25 1976-12-30 Bactex Inc Pili von neisseria genorrhoeae und verfahren zu deren herstellung
ZA767577B (en) * 1976-01-29 1977-11-30 American Cyanamid Co Method of extracting and using antigen and products prepared therefrom
FR2397839A1 (fr) * 1977-07-18 1979-02-16 Grimberg Georges Compose donnant un vaccin oral intestinal
US4220638A (en) * 1978-10-12 1980-09-02 Merck & Co., Inc. Antigenic complex from N. Gonorrhoeae
US4443431A (en) * 1981-05-27 1984-04-17 The United States Of America As Represented By The Department Of Health And Human Services Neisseria gonorrhoeae vaccine
GB8506373D0 (en) * 1985-03-12 1985-04-11 Axon Healthcare Ltd Antigens antibodies
DD268868A1 (de) * 1987-04-03 1989-06-14 Forsch Lungenkrankheiten Und T Verfahren zur besseren herstellung lokal biologisch wirkender praeparate
US5512288A (en) * 1992-12-04 1996-04-30 University Technologies International, Inc. Giardia vaccine

Also Published As

Publication number Publication date
IL115197A (en) 1999-07-14
IL115197A0 (en) 1995-12-31
CN1159760A (zh) 1997-09-17
FI970933A7 (fi) 1997-05-05
EP0779817A1 (fr) 1997-06-25
NO971003D0 (no) 1997-03-05
AU3353095A (en) 1996-03-27
JPH10505083A (ja) 1998-05-19
KR970705409A (ko) 1997-10-09
MX9701730A (es) 1997-10-31
FI970933A0 (fi) 1997-03-05
FI970933L (fi) 1997-05-05
NO971003L (no) 1997-05-06
ZA957482B (en) 1997-03-06
WO1996007426A1 (fr) 1996-03-14
GB9417880D0 (en) 1994-10-26

Similar Documents

Publication Publication Date Title
CN1192151A (zh) 药用的微胶囊化乳芽孢杆菌
KR100333113B1 (ko) 헬리코박터피롤리관련위십이지장질환의치료방법
CN1222081A (zh) 预防和治疗乳腺炎的方法
US4873090A (en) Non-adjuvenated vaccine
WO2003018031A2 (fr) Azithromycine unidose
CA2382887A1 (fr) Compositions immunostimulantes
JPH07108857B2 (ja) 炎症過程及びアレルギー性疾患の予防及び治療のための細菌性製剤
US6242424B1 (en) Moenomycin and its derivatives for the production of pharmaceuticals, and pharmaceuticals containing moenomycin or its derivatives
EP0779817A1 (fr) Vaccin contre des infections vaginales s'administrant par voie enterique
Bengtsson et al. Trimethoprim-sulphamethoxazole treatment in staphylococcal endocarditis and gram-negative septicemia
Garrod Chemoprophylaxis
EP0225329B1 (fr) Vaccin sans adjuvant
AU5266999A (en) Enteral vaccine for vaginal infections
US4287173A (en) Vaccine for dental caries
JP2712000B2 (ja) Ｃ型肝炎治療剤
CN1259873A (zh) 以枯草芽孢杆菌活培养物为基的生物药制剂,治疗细菌、病毒感染和免疫缺陷症的方法
MXPA97001730A (es) Vacuna enteral para infecciones vaginales
HU180005B (en) Process for producing pharmaceutical composition utilizable for treating illnesses of respiratory organs
Eriksson et al. Absorption of erythromycin from pediatric suspension in infants and children
Salo et al. Efficacy and tolerability of erythromycin acistrate and erythromycin stearate in acute skin infections of patients with atopic eczema
Gorbach et al. Microbiology and antibiotic resistance in odontogenic infections
James et al. Failure of post-bacteraemia delayed antibiotic prophylaxis of experimental rabbit endocarditis
RU2189811C2 (ru) Способ профилактики и лечения респираторных болезней телят
Brevet-Coupe et al. Failure of pristinamycin treatment in a case of pneumonia caused by a streptogramins B-type resistant pneumococcus
Powell et al. Oral immunity tests of dysentery antigen in white mice

Legal Events

Date Code Title Description
FZDE Discontinued